Home   Chapter Home   Jobs   Conferences   Fellowships   Books

 

 

 

 

Breast-malignant, males, children

Morphologic variants of DCIS

Apocrine DCIS

 

Author: Nat Pernick, M.D, PathologyOutlines.com, Inc.

Reviewer: Daniel Visscher, M.D., University of Michigan Hospitals, February 2009 (see Reviewers page)

Revised: 15 August 2009

Last major update: August 2009

Copyright: (c) 2002-2009, PathologyOutlines.com, Inc.

 

Definition

=========================================================================

DCIS with cells containing abundant eosinophilic cytoplasm, vesicular nuclei and prominent nucleoli

● Uncommon variant; clinical behavior similar to classic DCIS

 

Microscopic description / grading

=========================================================================

Tumor grade is based on nuclear features and presence of comedo-type necrosis (Hum Path 2001;32:487)

● Low grade lesions have micropapillary architecture

● Lesion size / extent are important in differential diagnosis due to partial overlap with apocrine atypia

● Nuclei are graded 1-3 based on nuclear size, pleomorphism and nucleoli
● Nuclear size (compared to benign apocrine cells) is either small (1-2x), intermediate (3-4x) or large (5x or larger)

● Grade 1 nuclei: low pleomorphism, small/intermediate size, usually single prominent nucleolus

● Grade 2 nuclei: moderate pleomorphism, small/intermediate size, multiple nucleoli; may have occasional large nuclei or multinucleated cells

● Grade 3 nuclei: intermediate/large size, marked pleomorphism, coarse chromatin, irregular nuclear contour, frequently multiple nucleoli
● Necrosis: focal or extensive comedo-type necrosis, must be centrally localized in at least 1 duct or acinus; isolated necrotic or apoptotic cells are ignored

● Low-grade: nuclear grade 1 or 2 without necrosis
● High-grade: tumors with grade 3 nuclei and necrosis; similar to high grade nonapocrine DCIS, but with cytoplasmic apocrine features and 10%+ nuclei with single large nucleolus and vesicular chromatin

● Intermediate-grade: cases not classified as low or high histologic grade

 

Micro images

=========================================================================

 

                                    

Comedonecrosis                                Present in adenosis                          Apocrine-type cells

 

 

                             

Granular cytoplasm                           Involving lobules                                 Forming tufts

 

 

                             

Secretory features #1                       #2                                                           #3

 

 

                    

Secretory features #4                       #5

 

 

                                                        

Low power                                           Intermediate power                           High power

 

 

                      

Cells have abundant cytoplasm, vesicular nuclei and prominent nucleoli (AFIP)

 

 

                                               

Micropapillary pattern                       Cribriform pattern

 

 

Apocrine adenosis with atypia (not DCIS)

 

 

Androgen receptor staining

 

Virtual slides

=========================================================================

 

High grade apocrine DCIS

 

Positive stains

=========================================================================

● Androgen receptor, B72.3 (92%, APMIS 2006;114:712), ER-beta (73%, Histopathology 2007;50:425)

p53 (62%), HER2 (47%), Ki-67 (5% of cells) (Mod Path 2000;13:13)

 

Negative stains

=========================================================================

ER-alpha, PR, bcl2

 

Additional references

=========================================================================

Hum Path 1994;25:164, Mod Path 1994;7:813, Stanford University

 

End of Breast – Malignant, Males, Children > Apocrine DCIS

 

 

 

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment.  This website should not be used as a substitute for the advice of a licensed physician.

 

All information on this website is protected by Copyright, (c) 2001-2009, PathologyOutlines.com, Inc.  Information from third parties may also be protected by copyright.  Please contact us at copyrightPathOut@gmail.com with any questions.